Habibeh Khoshbouei, PhD, PharmD - Publications

Affiliations: 
Neuroscience University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Dopamine Transporter

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Streit WJ, Khoshbouei H, Bechmann I. Dystrophic microglia in late-onset Alzheimer's disease. Glia. PMID 31922322 DOI: 10.1002/glia.23782  0.36
2019 Lebowitz JJ, Khoshbouei H. Heterogeneity of dopamine release sites in health and degeneration. Neurobiology of Disease. 134: 104633. PMID 31698055 DOI: 10.1016/j.nbd.2019.104633  0.32
2019 Gopinath A, Doty A, Mackie PM, Hashimi B, Francis M, Saadatpour L, Saha K, Shaw G, Ramirez-Zamora A, Okun MS, Streit WJ, Khoshbouei H. A novel approach to study markers of dopamine signaling in peripheral immune cells. Journal of Immunological Methods. 112686. PMID 31634479 DOI: 10.1016/j.jim.2019.112686  0.36
2019 Miller DR, Lebowitz JJ, Guenther DT, Refowich AJ, Hansen C, Maurer AP, Khoshbouei H. Methamphetamine regulation of activity and topology of ventral midbrain networks. Plos One. 14: e0222957. PMID 31536584 DOI: 10.1371/journal.pone.0222957  0.36
2019 Ahmari N, Santisteban MM, Miller DR, Geis NM, Larkin RM, Redler TL, Denson H, Khoshbouei H, Baekey DM, Raizada MK, Zubcevic J. Elevated bone marrow sympathetic drive precedes systemic inflammation in angiotensin II hypertension. American Journal of Physiology. Heart and Circulatory Physiology. PMID 31150271 DOI: 10.1152/ajpheart.00510.2018  0.36
2019 Lebowitz JJ, Pino JA, Mackie PM, Lin M, Hurst C, Divita K, Collins AT, Koutzoumis DN, Torres GE, Khoshbouei H. Clustered Kv2.1 decreases dopamine transporter activity and internalization. The Journal of Biological Chemistry. PMID 30824538 DOI: 10.1074/jbc.RA119.007441  0.32
2018 Shaerzadeh F, Streit WJ, Heysieattalab S, Khoshbouei H. Methamphetamine neurotoxicity, microglia, and neuroinflammation. Journal of Neuroinflammation. 15: 341. PMID 30541633 DOI: 10.1186/s12974-018-1385-0  0.36
2018 Streit WJ, Braak H, Del Tredici K, Leyh J, Lier J, Khoshbouei H, Eisenlöffel C, Müller W, Bechmann I. Microglial activation occurs late during preclinical Alzheimer's disease. Glia. PMID 30417428 DOI: 10.1002/glia.23510  0.36
2018 Miller DR, Shaerzadeh F, Phan L, Sharif N, Gamble-George J, McLaughlin JP, Streit WJ, Khoshbouei H. HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific. Glia. PMID 29733459 DOI: 10.1002/glia.23447  0.36
2018 Sharma RK, Oliveira AC, Kim S, Rigatto K, Zubcevic J, Rathinasabapathy A, Kumar A, Lebowitz JJ, Khoshbouei H, Lobaton G, Aquino V, Richards EM, Katovich MJ, Shenoy V, Raizada MK. Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension. Hypertension (Dallas, Tex. : 1979). PMID 29712738 DOI: 10.1161/HYPERTENSIONAHA.118.10934  0.32
2018 Mackie P, Lebowitz J, Saadatpour L, Nickoloff E, Gaskill P, Khoshbouei H. The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease. Brain, Behavior, and Immunity. PMID 29551693 DOI: 10.1016/j.bbi.2018.03.020  0.36
2018 Sambo DO, Lebowitz JJ, Khoshbouei H. The Sigma-1 Receptor as a Regulator of Dopamine Neurotransmission: A Potential Therapeutic Target for Methamphetamine Addiction. Pharmacology & Therapeutics. PMID 29360540 DOI: 10.1016/j.pharmthera.2018.01.009  0.32
2017 Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, Shetty M, Rodriquez M, Alonge T, Ali M, Katz J, Yan L, Febo M, Henry LK, Bruijnzeel AW, ... ... Khoshbouei H, et al. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nature Communications. 8: 2228. PMID 29263318 DOI: 10.1038/s41467-017-02087-x  0.32
2017 Gaskill P, Miller D, George JG, Yano H, Khoshbouei H. HIV, Tat and dopaminergic transmission. Neurobiology of Disease. PMID 28457951 DOI: 10.1016/j.nbd.2017.04.015  0.36
2016 Lin M, Sambo D, Khoshbouei H. Methamphetamine Regulation of Firing Activity of Dopamine Neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 10376-10391. PMID 27707972 DOI: 10.1523/JNEUROSCI.1392-16.2016  0.64
2016 Sacino AN, Brooks MM, Chakrabarty P, Saha K, Khoshbouei H, Golde TE, Giasson BI. Proteolysis of α-Synuclein Fibrils in the Lysosomal Pathway Limits Induction of Inclusion Pathology. Journal of Neurochemistry. PMID 27424880 DOI: 10.1111/jnc.13743  0.64
2016 Richardson BD, Saha K, Krout D, Cabrera E, Felts B, Henry LK, Swant J, Zou MF, Newman AH, Khoshbouei H. Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane. Nature Communications. 7: 10423. PMID 26804245 DOI: 10.1038/ncomms10423  0.64
2015 Heysieattalab S, Naghdi N, Zarrindast MR, Haghparast A, Mehr SE, Khoshbouei H. The effects of GABAA and NMDA receptors in the shell-accumbens on spatial memory of METH-treated rats. Pharmacology, Biochemistry, and Behavior. PMID 26708956 DOI: 10.1016/j.pbb.2015.12.008  0.64
2015 Butler B, Saha K, Rana T, Becker JP, Sambo D, Davari P, Goodwin JS, Khoshbouei H. Dopamine Transporter Activity Is Modulated by α-Synuclein. The Journal of Biological Chemistry. PMID 26442590 DOI: 10.1074/jbc.M115.691592  0.64
2014 Butler B, Gamble-George J, Prins P, North A, Clarke JT, Khoshbouei H. Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice. Journal of Addiction & Prevention. 2. PMID 25621291  0.36
2014 Saha K, Sambo D, Richardson BD, Lin LM, Butler B, Villarroel L, Khoshbouei H. Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing. The Journal of Biological Chemistry. 289: 22246-57. PMID 24962577 DOI: 10.1074/jbc.M114.563056  0.64
2013 Roth JA, Li Z, Sridhar S, Khoshbouei H. The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells. Neurotoxicology. 35: 121-8. PMID 23313730 DOI: 10.1016/j.neuro.2013.01.002  0.64
2013 North A, Swant J, Salvatore MF, Gamble-George J, Prins P, Butler B, Mittal MK, Heltsley R, Clark JT, Khoshbouei H. Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit. Synapse (New York, N.Y.). 67: 245-57. PMID 23280858 DOI: 10.1002/syn.21635  0.64
2012 Saha K, Swant J, Khoshbouei H. Single cell measurement of dopamine release with simultaneous voltage-clamp and amperometry. Journal of Visualized Experiments : Jove. PMID 23207721 DOI: 10.3791/3798  0.64
2012 Li Z, Chadalapaka G, Ramesh A, Khoshbouei H, Maguire M, Safe S, Rhoades RE, Clark R, Jules G, McCallister M, Aschner M, Hood DB. PAH particles perturb prenatal processes and phenotypes: protection from deficits in object discrimination afforded by dampening of brain oxidoreductase following in utero exposure to inhaled benzo(a)pyrene. Toxicological Sciences : An Official Journal of the Society of Toxicology. 125: 233-47. PMID 21987461 DOI: 10.1093/toxsci/kfr261  0.64
2012 Butler B, Saha K, Khoshbouei H. α-synuclein regulation of dopamine transporter Translational Neuroscience. 3: 249-257. DOI: 10.2478/s13380-012-0036-7  0.64
2011 Swant J, Goodwin JS, North A, Ali AA, Gamble-George J, Chirwa S, Khoshbouei H. α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. The Journal of Biological Chemistry. 286: 43933-43. PMID 21990355 DOI: 10.1074/jbc.M111.241232  0.64
2011 Hood DB, Ramesh A, Chirwa S, Khoshbouei H, Archibong AE. Developmental Toxicity of Polycyclic Aromatic Hydrocarbons Reproductive and Developmental Toxicology. 593-606. DOI: 10.1016/B978-0-12-382032-7.10044-X  0.64
2010 Swant J, Chirwa S, Stanwood G, Khoshbouei H. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. Plos One. 5: e11382. PMID 20614033 DOI: 10.1371/journal.pone.0011382  0.64
2009 Goodwin JS, Larson GA, Swant J, Sen N, Javitch JA, Zahniser NR, De Felice LJ, Khoshbouei H. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo. The Journal of Biological Chemistry. 284: 2978-89. PMID 19047053 DOI: 10.1074/jbc.M805298200  0.64
2008 McCallister MM, Maguire M, Ramesh A, Aimin Q, Liu S, Khoshbouei H, Aschner M, Ebner FF, Hood DB. Prenatal exposure to benzo(a)pyrene impairs later-life cortical neuronal function. Neurotoxicology. 29: 846-54. PMID 18761371 DOI: 10.1016/j.neuro.2008.07.008  0.64
2008 Lute BJ, Khoshbouei H, Saunders C, Sen N, Lin RZ, Javitch JA, Galli A. PI3K signaling supports amphetamine-induced dopamine efflux. Biochemical and Biophysical Research Communications. 372: 656-61. PMID 18510945 DOI: 10.1016/j.bbrc.2008.05.091  0.64
2006 Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron. 51: 417-29. PMID 16908408 DOI: 10.1016/j.neuron.2006.06.028  0.64
2005 Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proceedings of the National Academy of Sciences of the United States of America. 102: 3495-500. PMID 15728379 DOI: 10.1073/pnas.0407737102  0.64
2004 Gnegy ME, Khoshbouei H, Berg KA, Javitch JA, Clarke WP, Zhang M, Galli A. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Molecular Pharmacology. 66: 137-43. PMID 15213305 DOI: 10.1124/mol.66.1.137  0.64
2004 Khoshbouei H, Sen N, Guptaroy B, Johnson L', Lund D, Gnegy ME, Galli A, Javitch JA. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. Plos Biology. 2: E78. PMID 15024426 DOI: 10.1371/journal.pbio.0020078  0.64
2003 Morilak DA, Cecchi M, Khoshbouei H. Interactions of norepinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress. Life Sciences. 73: 715-26. PMID 12801593 DOI: 10.1016/S0024-3205(03)00392-8  0.64
2003 Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. The Journal of Biological Chemistry. 278: 12070-7. PMID 12556446 DOI: 10.1074/jbc.M212815200  0.64
2002 Cecchi M, Khoshbouei H, Morilak DA. Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology. 43: 1139-47. PMID 12504920 DOI: 10.1016/S0028-3908(02)00292-7  0.64
2002 Khoshbouei H, Cecchi M, Morilak DA. Modulatory effects of galanin in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 25-34. PMID 12062904 DOI: 10.1016/S0893-133X(01)00424-9  0.64
2002 Cecchi M, Khoshbouei H, Javors M, Morilak DA. Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience. 112: 13-21. PMID 12044468 DOI: 10.1016/S0306-4522(02)00062-3  0.64
2002 Khoshbouei H, Cecchi M, Dove S, Javors M, Morilak DA. Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacology, Biochemistry, and Behavior. 71: 407-17. PMID 11830175 DOI: 10.1016/S0091-3057(01)00683-9  0.64
1998 Kolakowski LF, O'Neill GP, Howard AD, Broussard SR, Sullivan KA, Feighner SD, Sawzdargo M, Nguyen T, Kargman S, Shiao LL, Hreniuk DL, Tan CP, Evans J, Abramovitz M, Chateauneuf A, ... ... Khoshbouei H, et al. Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. Journal of Neurochemistry. 71: 2239-51. PMID 9832121  0.64
Show low-probability matches.